Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Oxytocin modulates hippocampal perfusion in people at clinical high risk for psychosis.
Davies C, Paloyelis Y, Rutigliano G, Cappucciati M, De Micheli A, Ramella-Cravaro V, Provenzani U, Antoniades M, Modinos G, Oliver D, Stahl D, Murguia S, Zelaya F, Allen P, Shergill S, Morrison P, Williams S, Taylor D, McGuire P, Fusar-Poli P. Davies C, et al. Among authors: murguia s. Neuropsychopharmacology. 2019 Jun;44(7):1300-1309. doi: 10.1038/s41386-018-0311-6. Epub 2019 Jan 9. Neuropsychopharmacology. 2019. PMID: 30626906 Free PMC article. Clinical Trial.
Neurochemical effects of oxytocin in people at clinical high risk for psychosis.
Davies C, Rutigliano G, De Micheli A, Stone JM, Ramella-Cravaro V, Provenzani U, Cappucciati M, Scutt E, Paloyelis Y, Oliver D, Murguia S, Zelaya F, Allen P, Shergill S, Morrison P, Williams S, Taylor D, Lythgoe DJ, McGuire P, Fusar-Poli P. Davies C, et al. Among authors: murguia s. Eur Neuropsychopharmacol. 2019 May;29(5):601-615. doi: 10.1016/j.euroneuro.2019.03.008. Epub 2019 Mar 28. Eur Neuropsychopharmacol. 2019. PMID: 30928180
Acute oxytocin effects in inferring others' beliefs and social emotions in people at clinical high risk for psychosis.
Schmidt A, Davies C, Paloyelis Y, Meyer N, De Micheli A, Ramella-Cravaro V, Provenzani U, Aoki Y, Rutigliano G, Cappucciati M, Oliver D, Murguia S, Zelaya F, Allen P, Shergill S, Morrison P, Williams S, Taylor D, Borgwardt S, Yamasue H, McGuire P, Fusar-Poli P. Schmidt A, et al. Among authors: murguia s. Transl Psychiatry. 2020 Jun 22;10(1):203. doi: 10.1038/s41398-020-00885-4. Transl Psychiatry. 2020. PMID: 32572020 Free PMC article. Clinical Trial.
"A stratified pathway to stent-free reperfusion: Selecting suitable patients in ST-elevation myocardial infarction".
Mila R, Albistur J, Valdez M, Loza G, Torrado J, Bachini J, Murguía S, Acquistapace F, Nóbile N, Briano V, Niggemeyer A, Trujillo P, Niell N, Durán A, Alfonso F, Dayan V. Mila R, et al. Among authors: murguia s. Cardiovasc Revasc Med. 2024 Sep 14:S1553-8389(24)00662-6. doi: 10.1016/j.carrev.2024.09.001. Online ahead of print. Cardiovasc Revasc Med. 2024. PMID: 39306485
Connectome dysfunction in patients at clinical high risk for psychosis and modulation by oxytocin.
Davies C, Martins D, Dipasquale O, McCutcheon RA, De Micheli A, Ramella-Cravaro V, Provenzani U, Rutigliano G, Cappucciati M, Oliver D, Williams S, Zelaya F, Allen P, Murguia S, Taylor D, Shergill S, Morrison P, McGuire P, Paloyelis Y, Fusar-Poli P. Davies C, et al. Among authors: murguia s. Mol Psychiatry. 2024 May;29(5):1241-1252. doi: 10.1038/s41380-024-02406-x. Epub 2024 Jan 19. Mol Psychiatry. 2024. PMID: 38243074 Free PMC article. Clinical Trial.
FGF1 supports glycolytic metabolism through the estrogen receptor in endocrine-resistant and obesity-associated breast cancer.
Castillo-Castrejon M, Sankofi BM, Murguia SJ, Udeme AA, Cen HH, Xia YH, Thomas NS, Berry WL, Jones KL, Richard VR, Zahedi RP, Borchers CH, Johnson JD, Wellberg EA. Castillo-Castrejon M, et al. Among authors: murguia sj. Breast Cancer Res. 2023 Aug 22;25(1):99. doi: 10.1186/s13058-023-01699-0. Breast Cancer Res. 2023. PMID: 37608351 Free PMC article.
Clinical practice guideline of the Interamerican Society of Cardiology on primary prevention of cardiovascular disease in women.
Del-Sueldo MA, Mendonça-Rivera MA, Sánchez-Zambrano MB, Zilberman J, Múnera-Echeverri AG, Paniagua M, Campos-Alcántara L, Almonte C, Paix-Gonzales A, Anchique-Santos CV, Coronel CJ, Castillo G, Parra-Machuca MG, Duro I, Varletta P, Delgado P, Volberg VI, Puente-Barragán AC, Rodríguez A, Rotta-Rotta A, Fernández A, Izeta-Gutiérrez AC, Ancona-Vadillo AE, Aquieri A, Corrales A, Simeone A, Rubilar B, Artucio C, Pimentel-Fernández C, Marques-Santos C, Saldarriaga C, Chávez C, Cáceres C, Ibarrola D, Barranco D, Muñoz-Ortiz E, Ruiz-Gastelum ED, Bianco E, Murguía E, Soto E, Rodríguez-Caballero F, Otiniano-Costa F, Valentino G, Rodríguez-Cermeño IB, Rivera IR, Gándara-Ricardo JA, Velásquez-Penagos JA, Torales J, Scavenius K, Dueñas-Criado K, García L, Roballo L, Kazelian LR, Coussirat-Liendo M, Costa-Almeida MC, Drever M, Lujambio M, Castro ML, Rodríguez-Sifuentes M, Acevedo M, Giambruno M, Ramírez M, Gómez N, Gutiérrez-Castillo N, Greatty O, Harwicz P, Notaro P, Falcón R, López R, Montefilpo S, Ramírez-Flores S, Verdugo S, Murguía S, Constantini S, Vieira TC, Michelis V, Serra CM. Del-Sueldo MA, et al. Among authors: murguia s. Arch Cardiol Mex. 2022;92(Supl 2):1-68. doi: 10.24875/ACM.22000071. Arch Cardiol Mex. 2022. PMID: 35666723 Free PMC article. English. No abstract available.